Literature DB >> 27349242

Beta-blockers in septic shock to optimize hemodynamics? No.

Anthony S McLean1, Fabio S Taccone2, Antoine Vieillard-Baron3,4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27349242     DOI： 10.1007/s00134-016-4407-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

1.  Relation of effective arterial elastance to arterial system properties.

Authors:  Patrick Segers; Nikos Stergiopulos; Nico Westerhof
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

Review 2.  Ventriculo-arterial coupling: concepts, assumptions, and applications.

Authors:  D A Kass; R P Kelly
Journal:  Ann Biomed Eng       Date:  1992       Impact factor: 3.934

3.  Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study.

Authors:  A Morelli; M Singer; V M Ranieri; A D'Egidio; L Mascia; A Orecchioni; F Piscioneri; F Guarracino; E Greco; M Peruzzi; G Biondi-Zoccai; G Frati; S M Romano
Journal:  Intensive Care Med       Date:  2016-04-21       Impact factor: 17.440

4.  Left ventricular global longitudinal strain is independently associated with mortality in septic shock patients.

Authors:  Wei-Ting Chang; Wen-Huang Lee; Wei-Ting Lee; Po-Sheng Chen; Yu-Ru Su; Ping-Yen Liu; Yen-Wen Liu; Wei-Chuan Tsai
Journal:  Intensive Care Med       Date:  2015-07-17       Impact factor: 17.440

5.  Influence of heart rate on left ventricular ejection fraction in human beings.

Authors:  D R Ricci; A E Orlick; E L Alderman; N B Ingels; G T Daughters; E B Stinson
Journal:  Am J Cardiol       Date:  1979-09       Impact factor: 2.778

6.  Left ventricular-arterial coupling relations in the normal human heart.

Authors:  M R Starling
Journal:  Am Heart J       Date:  1993-06       Impact factor: 4.749

7.  Left ventricular-arterial coupling in systemic hypertension: analysis by means of arterial effective and left ventricular elastances.

Authors:  A Cohen-Solal; B Caviezel; D Himbert; R Gourgon
Journal:  J Hypertens       Date:  1994-05       Impact factor: 4.844

8.  Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.

Authors:  Andrea Morelli; Christian Ertmer; Martin Westphal; Sebastian Rehberg; Tim Kampmeier; Sandra Ligges; Alessandra Orecchioni; Annalia D'Egidio; Fiorella D'Ippoliti; Cristina Raffone; Mario Venditti; Fabio Guarracino; Massimo Girardis; Luigi Tritapepe; Paolo Pietropaoli; Alexander Mebazaa; Mervyn Singer
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

9.  Ventriculoarterial decoupling in human septic shock.

Authors:  Fabio Guarracino; Baldassare Ferro; Andrea Morelli; Pietro Bertini; Rubia Baldassarri; Michael R Pinsky
Journal:  Crit Care       Date:  2014-04-24       Impact factor: 9.097

10.  Arterial-ventricular coupling with aging and disease.

Authors:  Paul D Chantler; Edward G Lakatta
Journal:  Front Physiol       Date:  2012-05-07       Impact factor: 4.566
View more
  3 in total

1.  Reliability of effective arterial elastance using peripheral arterial pressure as surrogate for left ventricular end-systolic pressure.

Authors:  Manuel Ignacio Monge Garcia; Zhongping Jian; Jos J Settels; Feras Hatib; Maurizio Cecconi; Michael R Pinsky
Journal:  J Clin Monit Comput       Date:  2018-12-14       Impact factor: 2.502

2.  The association between premorbid beta blocker exposure and mortality in sepsis-a systematic review.

Authors:  Kaiquan Tan; Martin Harazim; Benjamin Tang; Anthony Mclean; Marek Nalos
Journal:  Crit Care       Date:  2019-09-04       Impact factor: 9.097

3.  Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study.

Authors:  Martin Balik; Petr Waldauf; Michal Maly; Vojtech Matousek; Tomas Brozek; Jan Rulisek; Michal Porizka; Robert Sachl; Michal Otahal; Petr Brestovansky; Eva Svobodova; Marek Flaksa; Zdenek Stach; Jaroslav Pazout; Frantisek Duska; Ondrej Smid; Martin Stritesky
Journal:  BMJ Open       Date:  2019-09-03       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.